Special Issue "Latest Advances in Pancreatic Diseases"
Deadline for manuscript submissions: 1 August 2021.
Despite decades of effort, the diagnosis and management of the diseases of the pancreas is still a challenge due to the inaccessibility of this organ. There are multiple methods to evaluate the pancreas, but to date, few of them confirm the presence of any pancreatic disease or can help in monitoring treatment success.
Pancreatic cancer remains a lethal disease due to its rapid progression and early metastasis, with a life expectancy of less than 6 months and a 5-year survival rate of around 5%. Pancreatitis is an inflammatory disease of the pancreas. Its diagnosis, mainly based on the presence of morphological or functional changes, is difficult because no standard diagnostic criteria or method of diagnosing this pathology have been established. Diabetes is a disease characterized by β-cell destruction or dysfunction, resulting in progressive hyperglycemia. Finally, exocrine pancreatic insufficiency results from destruction of the pancreatic parenchyma, making it impossible to maintain the minimum production levels of digestive enzymes.
As early diagnosis is the best way to improve the clinical outcome of these patients, the lack of robust, accurate, and non-invasive methods to detect early stages of pancreatic diseases represents the most important obstacle to the improvement of outcomes. The present Issue aims to publish studies that propose new diagnostic or prognostic tools in the battle against pancreatic diseases.
Dr. Octavio Caba
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pancreatic diseases
- pancreatic cancer
- exocrine pancreatic insufficiency